AGA, in partnership with the Joint Task Force on Allergy-Immunology Practice Parameters on the Management of Eosinophilic Esophagitis (JTF), is seeking public comment on a new guideline for the management of eosinophilic esophagitis (EoE). This guideline addresses the clinical management of EoE for both pediatric and adult allergists and gastroenterologists. Unless specified, this guideline’s recommendations are applicable to the short-term treatment of EoE, as the current evidence-base is primarily comprised of trials extending from two to 16 weeks.
Review and submit feedback by May 16
AGA and the JTF are seeking public comment on the clinical practice guideline and technical review for the management of EoE. Please review the following documents:
Submit your comments by completing this survey. The public comment period will end at noon EDT on Thursday, May 16.
Learn more about AGA’s clinical practice guidelines.
